STOCK TITAN
  1. Home
  2. Sec-filings
  3. TAK
  4. [Form 3] TAKEDA PHARMACEUTICAL CO LTD Initial Statement of Beneficial Ownership

Takeda (TAK) director discloses shareholdings and equity-based awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Takeda Pharmaceutical Co Ltd director Michel Bruno Orsinger has filed an initial ownership report detailing his equity interests in the company. The filing lists direct holdings of 7,600 American Depositary Shares and 9,700 Ordinary Shares. It also shows several equity-based awards, including Tax Obligation Awards economically equivalent to 1,152, 1,192 and 1,180 Ordinary Shares, scheduled to vest on different future dates. A cash-settled retirement award is tied to 6,532 Ordinary Shares. Footnotes describe additional restricted stock unit grants that convert into Ordinary Shares or cash upon vesting, with specified vesting dates and retirement-based vesting conditions.

Positive

  • None.

Negative

  • None.
Insider Orsinger Michel Bruno
Role Director
Type Security Shares Price Value
holding Tax Obligation Award -- -- --
holding Tax Obligation Award -- -- --
holding Tax Obligation Award -- -- --
holding Cash Settled Retirement Award -- -- --
holding American Depositary Shares -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Tax Obligation Award — 1,152 shares (Direct); Cash Settled Retirement Award — 6,532 shares (Direct); American Depositary Shares — 7,600 shares (Direct); Ordinary Shares — 9,700 shares (Direct)
Footnotes (1)
  1. Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 ordinary shares), June 1, 2027 (3,400 ordinary shares) and June 1, 2028 (3,200 ordinary shares). Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive a cash amount equivalent to the value of one Ordinary Share at the time of vest. The RSUs vest upon the director's retirement from the board.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Orsinger Michel Bruno
(Last)(First)(Middle)
CHEMIN DE L'HORIZON 1
(Street)
BURSINEL1195
(City)(State)(Zip)
SWITZERLAND
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026		3. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depositary Shares7,600D
Ordinary Shares9,700(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Tax Obligation Award06/01/202606/01/2026Ordinary Shares1,152(2)D
Tax Obligation Award06/01/202706/01/2027Ordinary Shares1,192(2)D
Tax Obligation Award06/01/202806/01/2028Ordinary Shares1,180(2)D
Cash Settled Retirement Award (3) (3)Ordinary Shares6,532(3)D
Explanation of Responses:
1. Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 ordinary shares), June 1, 2027 (3,400 ordinary shares) and June 1, 2028 (3,200 ordinary shares).
2. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
3. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive a cash amount equivalent to the value of one Ordinary Share at the time of vest. The RSUs vest upon the director's retirement from the board.
Remarks:
Exhibit 24 Power of Attorney
/s/ Max Heuer, by power of attorney, for Michel Orsinger03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does Michel Bruno Orsinger’s Form 3 filing for TAKEDA PHARMACEUTICAL CO LTD show?

The Form 3 shows Michel Bruno Orsinger’s initial ownership in Takeda, including 7,600 American Depositary Shares, 9,700 Ordinary Shares, and multiple equity-based awards referenced to specific numbers of Ordinary Shares and vesting conditions.

How many Takeda American Depositary Shares and Ordinary Shares does Michel Orsinger report holding?

Michel Orsinger reports direct holdings of 7,600 American Depositary Shares and 9,700 Ordinary Shares of Takeda. These positions sit alongside various awards and restricted stock units that are linked to additional Ordinary Share equivalents and future vesting or payment events.

What are the Tax Obligation Awards reported by Michel Orsinger in his Takeda Form 3?

Tax Obligation Awards are described as the economic equivalent of one Ordinary Share each, converting at vest to a cash payment mainly covering tax obligations at the then-current Ordinary Share market price. The filing lists awards tied to 1,152, 1,192 and 1,180 Ordinary Shares.

What is the cash-settled retirement award reported for Michel Orsinger at Takeda?

The cash-settled retirement award is linked to 6,532 Ordinary Shares. According to the footnote, the related RSUs entitle the holder to a cash amount equal to the value of one Ordinary Share for each unit, vesting upon the director’s retirement from the board.

Does Michel Orsinger’s Takeda Form 3 show any stock purchases or sales?

The entries are characterized as holdings, and the structured data show zero buy or sell transactions, indicating the Form 3 serves to disclose existing positions and awards rather than reporting new market purchases or sales of Takeda securities.